Arbutus Biopharma Corp at Chardan Genetic Medicines Conference (Virtual) Transcript
It's my pleasure to introduce our next guest from Arbutus Biopharma, President and Chief Executive Officer, William Collier; Chief Scientific Officer, Dr. Mike Sofia; Chief Development Officer, Dr. Gaston Picchio; and Chief Financial Officer, David Hastings. The format for this session is a 25--minute fireside chat. If any of our audience attendees have questions during the session, feel free to type them into the question box under the video player and we'll try to ask them on your behalf.
Questions & Answers
With that, Bill, Mike, Gaston, David, welcome. Well, let's start with you, Bill. Could you please provide a couple of minutes of introductory comments about the state of the business for Arbutus, summarizing your differential approach, and what's been achieved in 2021 year to date?
Yes, happy to. Thank you very much, Keay. Just so we can get
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
